Mesa Laboratories, Inc.
MLAB
$92.77
$1.571.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 101.50% | 99.36% | 99.75% | 99.22% | -26,412.55% |
| Total Depreciation and Amortization | 7.26% | -7.73% | -13.44% | -22.32% | -30.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.51% | -93.06% | -94.50% | -93.35% | 2,641.36% |
| Change in Net Operating Assets | -86.66% | -107.10% | -110.49% | 15.59% | 1,103.30% |
| Cash from Operations | -11.68% | 1.18% | -15.53% | 6.06% | 7.44% |
| Capital Expenditure | 10.85% | 15.45% | -36.98% | -65.52% | -31.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 101.21% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25.24% | 95.28% | 94.36% | 94.47% | 96.30% |
| Total Debt Issued | 46.33% | -25.59% | -92.73% | 3.47% | 3.47% |
| Total Debt Repaid | -25.72% | -26.91% | 60.33% | -245.70% | -290.62% |
| Issuance of Common Stock | 638.55% | 638.55% | 638.55% | 638.55% | -85.53% |
| Repurchase of Common Stock | -21.84% | -21.84% | -21.84% | -21.84% | -7,180.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.36% | -1.13% | -0.78% | -0.61% | -0.67% |
| Other Financing Activities | -598.21% | -466.36% | -730.17% | 46.64% | -132.87% |
| Cash from Financing | -2.52% | -243.18% | -232.13% | -235.55% | -199.69% |
| Foreign Exchange rate Adjustments | 12,342.86% | 27.24% | 1,888.67% | 464.07% | 107.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -172.51% | 65.29% | -84.25% | 80.98% | 28.69% |